HOLLISTON, Mass.--(BUSINESS WIRE)--Oligo Factory, a leading manufacturer of high-quality oligonucleotides at scale, announces today that it is compliant with current Good Manufacturing Practices (GMP) ...

EuBiologics announced on the 25th that its second factory in Chuncheon received a good manufacturing practice (GMP) adequacy judgment from the Ministry of Food and Drug Safety for its oral cholera ...

Samil Pharmaceutical announced on the 26th that its global ophthalmic CDMO factory located in Ho Chi Minh City, Vietnam, has received the 'Good Manufacturing Practice (GMP)' certification from the ...

Imexpharm, a leader in Vietnam’s pharmaceutical industry, is entering a new growth phase with a focus on the production of invented drugs, leveraging advanced technology to meet stringent ...

[Asia Economy Reporter Jang Hyowon] SNPE Genetics, a subsidiary of KOSDAQ-listed company GW Biotech, issued convertible bonds (CB) worth 10 billion KRW and repaid them early within just three weeks.

Research and development (R&D) is the formula that has created the strength of Vietnam's leading antibiotic brand Imexpharm. Holding leading position in antibiotics market According to the World ...

Oligo Factory, which manufactures oligonucleotides at scale, reports that it is compliant with current Good Manufacturing Practices (GMP). This milestone emphasizes Oligo Factory’s commitment to ...